Clopidogrel and Primrose oil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clopidogrel and Primrose oil. Common interactions include vomiting among females and confusional state among males.

The phase IV clinical study analyzes what interactions people who take Clopidogrel and Primrose oil have. It is created by eHealthMe based on reports of 13 people who take Clopidogrel and Primrose oil from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

13 people who take Clopidogrel and Primrose oil together, and have interactions are studied.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 79,618 Clopidogrel users for its effectiveness, alternative drugs and more.

What is Primrose oil?

Primrose oil has active ingredients of evening primrose oil. eHealthMe is studying from 1,612 Primrose oil users for its effectiveness, alternative drugs and more.

Number of Clopidogrel and Primrose oil reports submitted per year:

Common Clopidogrel and Primrose Oil drug interactions by gender *:

female:

Vomiting
Weight decreased
Balance disorder
Psoriasis
Diarrhoea
Alopecia
Gastric disorder
Lower respiratory tract infection

male:

Confusional state
Loss of consciousness
Muscle rigidity
Seizure

Common Clopidogrel and Primrose Oil drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Confusional state
Loss of consciousness
Muscle rigidity
Seizure
Balance disorder
Diarrhoea
Psoriasis
Gastric disorder
Vomiting
Weight decreased

Common conditions people have *:

Skin Ulcer: 5 people, 38.46%
Psoriasis (immune-mediated disease that affects the skin): 4 people, 30.77%
Cardiac Disorder: 2 people, 15.38%
Stress Gastritis (swelling (inflammation) and weakening of the stomach lining that occurs during a serious illness): 1 person, 7.69%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.69%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 7.69%
Acute Myocardial Infarction (acute heart attack): 1 person, 7.69%
Adverse Reaction: 1 person, 7.69%
Arrhythmias (irregular heartbeat): 1 person, 7.69%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Clopidogrel and Primrose oil?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Min IS, Lee JY, Jung TS, Kang NK, Park BB, Kim BK, "Development of a Complete Atrioventricular Block Associated with Intake of Evening Primrose Oil", The Korean Journal of Medicine, 2016 May .
Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .